Literature DB >> 30054791

Tc-99m pyrophosphate imaging for transthyretin cardiac amyloidosis: Importance of estimation of cancer risk with the modality.

Shivda Pandey1, Omar K Siddiqi2,3.   

Abstract

Entities:  

Year:  2018        PMID： 30054791     DOI： 10.1007/s12350-018-1362-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  13 in total

Review 1.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

2.  Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.

Authors:  D A Weber; P T Makler; E E Watson; J L Coffey; S R Thomas; J London
Journal:  J Nucl Med       Date:  1989-06       Impact factor: 10.057

3.  Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.

Authors:  Joel Buxbaum; Alice Alexander; James Koziol; Clement Tagoe; Ervin Fox; Dalane Kitzman
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

4.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

5.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

6.  Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Authors:  Selma F Mohammed; Sultan A Mirzoyev; William D Edwards; Ahmet Dogan; Donna R Grogan; Shannon M Dunlay; Veronique L Roger; Morie A Gertz; Angela Dispenzieri; Steven R Zeldenrust; Margaret M Redfield
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

7.  TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis.

Authors:  Hannah Rosenblum; Adam Castano; Julissa Alvarez; Jeff Goldsmith; Stephen Helmke; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2018-04       Impact factor: 8.790

8.  Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure.

Authors:  Marios Arvanitis; Gloria G Chan; Daniel R Jacobson; John L Berk; Lawreen H Connors; Frederick L Ruberg
Journal:  Amyloid       Date:  2017-10-20       Impact factor: 7.141

9.  Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

Authors:  Adam Castaño; David L Narotsky; Nadira Hamid; Omar K Khalique; Rachelle Morgenstern; Albert DeLuca; Jonah Rubin; Codruta Chiuzan; Tamim Nazif; Torsten Vahl; Isaac George; Susheel Kodali; Martin B Leon; Rebecca Hahn; Sabahat Bokhari; Mathew S Maurer
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

10.  Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.

Authors:  Thomas A Treibel; Marianna Fontana; Janet A Gilbertson; Silvia Castelletti; Steven K White; Paul R Scully; Neil Roberts; David F Hutt; Dorota M Rowczenio; Carol J Whelan; Michael A Ashworth; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2016-08       Impact factor: 7.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.